(5R,6R,8R,9R)-8-azido-9-[tert-butyl(dimethyl)silyl]oxy-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dioxo-1,7-dioxa-2lambda6-thiaspiro[4.4]non-3-en-4-amine | 160261-65-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: (5R,6R,8R,9R)-8-azido-9-[tert-butyl(dimethyl)silyl]oxy-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dioxo-1,7-dioxa-2lambda6-thiaspiro[4.4]non-3-en-4-amine
• 英文别名: (5R,6R,8R,9R)-8-azido-9-[tert-butyl(dimethyl)silyl]oxy-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dioxo-1,7-dioxa-2λ6-thiaspiro[4.4]non-3-en-4-amine
• CAS: 160261-65-4
• 化学式: C₁₉H₃₈N₄O₆SSi₂
• 分子量: 506.771
• InChiKey: FVODJODETWNBMC-YYAJDYIMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.33
• 重原子数：
  32
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  120
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  (5R,6R,8R,9R)-8-azido-9-[tert-butyl(dimethyl)silyl]oxy-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dioxo-1,7-dioxa-2lambda6-thiaspiro[4.4]non-3-en-4-amine 以 乙醇 、 甲苯 为溶剂， 反应 18.17h， 生成 <1-<2',5'-bis-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl>-4-(N-methylcarbamoyl)-1,2,3-triazole>-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide)
  参考文献：
  名称：

  1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity

  摘要：

  Several 4- or 5-monosubsituted and 4,5-disubstituted 1,2,3-triazole analogues of the anti-HIV-1 lead com pound [1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]thymine]-3'-spiro-5''(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO-T) have been prepared and evaluated as inhibitors of HIV-1-induced cytopathicity. These analogues have been prepared by 1,3-diplar cycloaddition of [2,5-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-spiro-5'-(4'-amino- and and 4'-(N-acetylamino)1',2'-oxathiole 2',2'-dioxide) (TSAO) azides to various substituted acetylenes. Several 4- and 5-substituted 1,2,3-triazole-TSAO analogues proved superior to the unsubstituted derivative by 1-2 orders of magnitude. In particular the 5-substituted amido-, (methylamido)-, and (dimethylamido)-1,2,3-triazole derivatives of TSAO were endowed with potent anti-HIV-1 activity (50% effective concentration: 0.056-0.52 mu M). They show a similar resistance spectrum as previously noted for TSAO-T and related derivatives.

  DOI：

  10.1021/jm00050a015
• 作为产物：
  描述：

  1,2-di-O-acetyl-5-O-benzoyl-3-C-cyano-3-O-mesyl-D-ribofuranose 在 4-二甲氨基吡啶 、 叠氮基三甲基硅烷 、 四氯化锡 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 甲胺 作用下， 以 乙醇 、 二氯甲烷 、 乙腈 为溶剂， 反应 209.0h， 生成 (5R,6R,8R,9R)-8-azido-9-[tert-butyl(dimethyl)silyl]oxy-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dioxo-1,7-dioxa-2lambda6-thiaspiro[4.4]non-3-en-4-amine
  参考文献：
  名称：

  1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity

  摘要：

  Several 4- or 5-monosubsituted and 4,5-disubstituted 1,2,3-triazole analogues of the anti-HIV-1 lead com pound [1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]thymine]-3'-spiro-5''(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO-T) have been prepared and evaluated as inhibitors of HIV-1-induced cytopathicity. These analogues have been prepared by 1,3-diplar cycloaddition of [2,5-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-spiro-5'-(4'-amino- and and 4'-(N-acetylamino)1',2'-oxathiole 2',2'-dioxide) (TSAO) azides to various substituted acetylenes. Several 4- and 5-substituted 1,2,3-triazole-TSAO analogues proved superior to the unsubstituted derivative by 1-2 orders of magnitude. In particular the 5-substituted amido-, (methylamido)-, and (dimethylamido)-1,2,3-triazole derivatives of TSAO were endowed with potent anti-HIV-1 activity (50% effective concentration: 0.056-0.52 mu M). They show a similar resistance spectrum as previously noted for TSAO-T and related derivatives.

  DOI：

  10.1021/jm00050a015

文献信息

• Abasic Analogues of TSAO-T as the First Sugar Derivatives That Specifically Inhibit HIV-1 Reverse Transcriptase
  作者：Sonsoles Velázquez、Cristina Chamorro、María-Jesús Pérez-Pérez、Rosa Alvarez、María-Luisa Jimeno、Angel Martín-Domenech、Carlos Pérez、Federico Gago、Erik De Clercq、Jan Balzarini、Ana San-Félix、María-José Camarasa

  DOI：10.1021/jm980370m

  日期：1998.11.1

  3-spiro sugar derivatives substituted at the anomeric position with nonaromatic rings or with amine, amide, urea, or thiourea moieties that mimic parts or the whole thymine base of TSAO-T. Also, a dihydrouracil TSAO analogue and O-glycosyl 3-spiro sugar derivatives substituted at the anomeric position with methyloxy or benzyloxy groups have been prepared. Compounds substituted at the anomeric position

  为了评估TSAO-T的胸腺嘧啶碱基可能在TSAO化合物与HIV-1逆转录酶（RT）相互作用中发挥的作用，我们设计，合成并评估了它们的抗HIV-1活性。系列的3-螺糖衍生物，在异头位置被非芳族环或被胺，酰胺，脲或硫脲部分取代，它们模拟TSAO-T的部分或整个胸腺嘧啶碱基。而且，已经制备了在异头位置被甲氧基或苄氧基取代的二氢尿嘧啶TSAO类似物和O-糖基3-螺糖衍生物。在异头位置分别被叠氮基，氨基或甲氧基取代的化合物没有明显的抗病毒活性（EC50：10-200 microM）。但是，取代的脲糖衍生物导致抗病毒效力增加（EC50：0。35-4 microM），其中最紧密模仿完整TSAO-T分子的那些尿素衍生物保留了最高的抗病毒活性。同样，二氢尿嘧啶TSAO衍生物保留了明显的抗HIV-1活性。这些化合物均未显示出任何抗HIV-2活性。本文所述的结果代表了以特定方式与HIV-1 RT相互作用的糖衍生
• TSAO Derivatives: Highly Specific Inhibitors of Human Immunodeficiency Virus Type-1 (HIV-1) Replication
  作者：Maria Camarasa、Maria Péarez-Péarez、Sonsoles Velázquez、Ana San-Féalix、Rosa Alvarez、Simon Ingate、Maria Luisa Jimeno、Anna Karlsson、Erik De Clercq、Jan Balzarini

  DOI：10.1080/15257779508012432

  日期：1995.5.1

  TSAO derivatives represent a unique class of nucleosides that are specifically targeted at HIV-1 RT. This overview is focussed on the chemical synthesis, the conformational studies, the antiviral and metabolic properties of TSAO derivatives, as well as their mechanism of antiviral action and the molecular basis of the vapid selection of resistant HIV-1 strains that emerge in cell culture in the presence of TSAO derivatives.
• Synthesis and Anti-HIV-1 Activity of 4- and 5-Substituted 1,2,3-Triazole-TSAO Derivatives
  作者：Ana San-Féalix、Rosa Alvarez、Sonsoles Veláazquez、Erik De Clercq、Jan Balzarini、María José Camarasa

  DOI：10.1080/15257779508012433

  日期：1995.5.1

  Several 4- or 5-monosubstituted and 4,5-disubstituted 1,2,3-triazole analogues of the anti-HIV-1 lead compound [1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]thymine]-3'-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dionide) (TSAO-T) have been prepared and evaluated for their inhibitory effect against HIV-1-induced cytopathicity.